openPR Logo
Press release

IgA Nephropathy Therapeutics Analysis by Key Players Mallinckrodt Pharmaceuticals, Merck Group, Novartis, Shire

11-26-2018 10:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

IgA Nephropathy Therapeutics Analysis by Key Players

The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the period 2016 – 2025.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample

*Technological Advancements at Cellular and Molecular Level Strengthening the IgA Nephropathy Pipeline

Various new technologies are being used by the companies for the development of drugs to treat IgA nephropathy. For instance, TARGIT drug delivery technology is being used by Calliditas Therapeutics AB for the development of novel drug therapies.

Some of the key players developing drugs for the treatment of IgA nephropathy include Mallinckrodt plc, Merck KGaA, Novartis AG, and Shire plc.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis

*Insights on Pipeline Segments

The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration.

Browse report at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis

*Promising Targets Spur the IgA Nephropathy Pipeline Growth

Companies are developing drugs with promising targets for the treatment of the disease. The potential targets may possibly stop or slow the progression of the disease with better efficacy and less side effects. Potential targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS), melanocortin receptors, and NF-κB signaling can also prove to be effective in IgA nephropathy treatment, since clinical trials of drug candidates meant to act on these targets have shown promising results. This is encouraging companies to further invest in their pipeline to develop drugs acting on new targets, thereby, fueling the growth of the pipeline.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347 5th Ave. #1402- 210
New York City, NY 10016 United States
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IgA Nephropathy Therapeutics Analysis by Key Players Mallinckrodt Pharmaceuticals, Merck Group, Novartis, Shire here

News-ID: 1400041 • Views: 1268

More Releases from P&S Intelligence

AR and VR Market Drivers, Restraints, Opportunities, and Trends in Coming Years
The augmented reality (AR) and virtual reality (VR) market is expected to witness a strong CAGR, of 42.9%, during the forecast period (2020–2030), owing to the soaring focus of vendors on price reduction, growing penetration of tablet computers and smartphones, and surging adoption of AR and VR technologies in the healthcare, gaming, tourism, education, and entertainment industries. According to P&S Intelligence, the market was valued at $37.0 billion in 2019
RF Transceiver Market Drivers, Restraints, Opportunities, and Trends in Coming Y …
The major factors responsible for the growth of the radiofrequency (RF) transceiver market are the increasing demand for smartphones and rising penetration of the internet of things (IoT) technology. Due to this, the revenue generated by the market players, which stood at $3,892.1 million in 2019, is projected to grow at a 0.8% CAGR during 2020–2030 (forecast period), to reach $3,384.5 million by 2030. The RF transceiver is an important
HVAC Market Drivers, Restraints, Opportunities, and Trends in Coming Years
Factors such as the growing construction sector, increasing government initiatives to support the installation of heating, ventilation, and air conditioning (HVAC) systems, surging demand for energy-efficient systems, and rising global surface temperature are expected to drive the growth of the HVAC market at a 4.8% CAGR during the forecast period (2020–2030). With this growth rate, the market size will increase from $240.8 billion in 2019 to $358.1 billion by 2030. Get
U.A.E HVAC Market Recent Trends, Developments, Challenges and Opportunities
A surge in construction activities in the transportation sector of the U.A.E. has led to the widescale adoption of heating, air conditioning, and ventilating (HVAC) systems in the country. The gulf country is spending hefty amounts on the construction of airports and expansion of railway infrastructure. These new facilities adopt HVAC equipment to offer better amenities. For example, the U.A.E. government launched "Route 2020" in 2018, to extend the Red

All 5 Releases


More Releases for IgA

Identity Governance and Administration (IGA) Market Trends, Analysis by Regions, …
Identity Governance and Administration (IGA) is commonly defined as the policy-based centralized set up of user identity management and access control. Identity governance and Administration helps support enterprise IT security and regulatory compliance. Due to increase in adoption of identity governance in the organization it is expected that Identity Governance and Administration (IGA) market will grow in the recent times. The rising advent of globalization and the rise in regulatory compliances
Identity Management Software Market Growth Attributed to Novel Breakthrough in I …
Emergence of hybrid IT environment across enterprises has necessitated adoption of identity management software system for enforcing authorized access to network applications, favoring secure enterprise data access and security. Novel development in identity governance and administration is attributed as chief growth enabler in identity management software market. In a recently added research report, ‘Global Identity Management Software Market Size, Status and Forecast 2018-2025’, Market Research Hub (MRH) collates core developments and
North America has been the Largest Global Identity Governance and Administration …
Global IGA market is on the rise due to increasing demand from enterprises to identify their users, control whatever they can access, and further audit their activities for security of information. Apart from this, since IGA also provides businesses with numerous supplementary functions, including auditing and policy management, its adoption by business leaders across industries, is expected to escalate in near future. The global IGA market is segmented on the
Technological Advancements at Cellular and Molecular Level Strengthening the IgA …
The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the
IgA Nephropathy Exhibits Emerging Pipeline with 11+ Drug Candidates
The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates, of which one drug candidate is in Phase III stage, five drug candidates are in Phase II stage and three drug candidates are in Pre-Clinical stage. Also, there are two inactive drug candidates and one discontinued drug candidate. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in
IVU app keeps IGA visitors informed
IVU supplies guidance and information system for IGA 2017 Berlin, 4 April 2017 – This year’s International Garden Show will draw crowds to Berlin with flowers, indoor and outdoor exhibitions and events. An app created by IVU Traffic Technologies AG on behalf of the state of Berlin will help visitors to find their way around the site and discover the various attractions. The application also meets the special requirements of people